In recent years, there is growing evidence that the activation of the PI3K/Akt path facilitates the improvement of cardiac fibrosis in models from ischemia/reperfusion to AMI and diabetic cardiomyopathy (20–22). This evidence concerns the gene AKT1 and diabetic cardiomyopathy.